Lansoprazol Alter

Lansoprazole, the active ingredient in Lansoprazol Alter, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is used to treat conditions such as gastro‑oesophageal reflux disease, peptic ulcer disease and to aid Helicobacter pylori eradication regimens.

GNH USA supplies Lansoprazol Alter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, transplant centres and oncology clinics worldwide, ensuring quality and regulatory compliance across global markets with reliable logistics and support.

Lansoprazole is a proton pump inhibitor used to manage acid‑related gastrointestinal disorders. - Gastro‑oesophageal reflux disease (GERD): reduces acid exposure, relieving symptoms and healing esophageal damage. - Peptic ulcer disease: promotes ulcer healing and helps prevent recurrence. - Helicobacter pylori eradication: used as part of combination therapy to increase eradication rates.

Lansoprazole may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: mild to moderate headache reported. - Diarrhea: loose stools or increased frequency. - Nausea: feeling of sickness or urge to vomit. - Abdominal pain: discomfort or cramping in the stomach area. - Flatulence: increased gas production. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with rash, swelling, breathing difficulty. - Stevens‑Johnson syndrome: rare skin disorder with blistering and detachment. - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Hypomagnesemia: low blood magnesium causing muscle cramps or arrhythmia. - Bone fracture: increased risk of hip or wrist fractures with long‑term use. - Elevated liver enzymes: signs of liver injury indicated by lab tests.

When prescribing lansoprazole, several safety considerations should be reviewed to minimize risk. - Assess renal function: adjust use in severe renal impairment. - Monitor magnesium levels: prolonged therapy may cause hypomagnesemia. - Avoid concomitant use with certain antiretrovirals: may reduce efficacy of those agents. - Use with caution in patients with hepatic disease: dose may need adjustment. - Discontinue before elective surgery: to reduce risk of postoperative complications. - Store at room temperature: keep in original container, protect from moisture and light.

Lansoprazole can affect the pharmacokinetics of several medicines; interactions range from major to moderate.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased absorption of atazanavir. - Methotrexate: increased toxicity. - Warfarin: may increase INR. - Ketoconazole: reduced azole absorption.

Moderate Interactions (Monitor Closely): - Digoxin: may increase serum levels. - Phenytoin: may reduce phenytoin levels. - Diazepam: may increase sedation. - Iron supplements: decrease lansoprazole absorption. - Vitamin B12: long‑term use may impair absorption.